Medicare Enrolled
Dr. Mudussara Khan, MD
Hematology · Daytona Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khan
Dr. Mudussara Khan is a hematology specialist in Daytona Beach, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Khan performed 46,184 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Khan received a total of $11,435 from 82 pharmaceutical and/or device companies across 667 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ 46,184 Medicare services
$11,435 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 114473 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗46,184
Medicare services
Bottom 35% in FL for hematology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
17,138 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 9,600 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 7,020 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 4,260 | $18 | $51 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,542 | $0 | $3 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,090 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
893 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 870 | $1 | $28 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
418 | $10 | $69 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
414 | $95 | $339 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
339 | $12 | $61 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
303 | $64 | $239 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
300 | $97 | $378 |
| Anti-nausea injection (ondansetron/Zofran) | 276 | $0 | $9 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
242 | $1 | $6 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
173 | $2 | $41 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
151 | $6 | $69 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
138 | $47 | $189 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
115 | $94 | $285 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
85 | $1 | $3 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
80 | $49 | $178 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
75 | $22 | $84 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
57 | $2 | $7 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
56 | $21 | $79 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
56 | $63 | $197 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
55 | $24 | $156 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
51 | $25 | $89 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
50 | $3 | $11 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
48 | $134 | $556 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
46 | $126 | $453 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
44 | $9 | $42 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
36 | $2 | $8 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
36 | $27 | $156 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
29 | $42 | $170 |
| New patient office visit, complex (60-74 min) | 28 | $166 | $585 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
24 | $18 | $59 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
21 | $1 | $7 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
13 | $4 | $10 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $103 | $377 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
38.7% high complexity
54.6% medium
6.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,435
Total received (2018-2024)
Avg $1,634/year across 7 years
Top 39% in FL for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
82
Companies
667
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,515
2023
$2,584
2022
$1,413
2021
$24
2020
$759
2019
$1,902
2018
$2,238
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$227
Merck Sharp & Dohme LLC
$218
PFIZER INC.
$210
AstraZeneca Pharmaceuticals LP
$182
Celgene Corporation
$141
Gilead Sciences, Inc.
$110
Stemline Therapeutics Inc.
$77
Eisai Inc.
$70
Blueprint Medicines Corporation
$66
ARRAY BIOPHARMA INC
$66
E.R. Squibb & Sons, L.L.C.
$66
Astellas Pharma US Inc
$64
Incyte Corporation
$62
Daiichi Sankyo Inc.
$62
GENZYME CORPORATION
$59
Lilly USA, LLC
$59
SOBI, INC
$56
TAIHO ONCOLOGY, INC.
$46
Bayer Healthcare Pharmaceuticals Inc.
$44
TerSera Therapeutics LLC
$44
EMD Serono, Inc.
$42
Exelixis Inc.
$40
Pharmacosmos Therapeutics Inc.
$38
PharmaEssentia USA Corporation
$38
Janssen Biotech, Inc.
$35
Janssen Pharmaceuticals, Inc
$35
Genentech USA, Inc.
$34
Takeda Pharmaceuticals U.S.A., Inc.
$32
BeiGene USA, Inc.
$29
JAZZ PHARMACEUTICALS INC.
$29
GlaxoSmithKline, LLC.
$28
Alnylam Pharmaceuticals Inc.
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
ABBVIE INC.
$23
Mirati Therapeutics, Inc.
$23
CSL Behring
$22
Kite Pharma, Inc.
$21
Coherus Biosciences Inc.
$16
PUMA BIOTECHNOLOGY, INC.
$16
Regeneron Healthcare Solutions, Inc.
$16
Ipsen Biopharmaceuticals, Inc
$15
Top 3 companies account for 26.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,283
Celgene Corporation
$670
Genentech USA, Inc.
$597
AstraZeneca Pharmaceuticals LP
$566
PFIZER INC.
$547
E.R. Squibb & Sons, L.L.C.
$525
Merck Sharp & Dohme LLC
$398
Janssen Biotech, Inc.
$386
Merck Sharp & Dohme Corporation
$377
Amgen Inc.
$369
Gilead Sciences, Inc.
$321
Seattle Genetics, Inc.
$303
GENZYME CORPORATION
$280
ABBVIE INC.
$252
Seagen Inc.
$252
Ipsen Biopharmaceuticals, Inc
$242
Lilly USA, LLC
$237
Incyte Corporation
$212
Bayer HealthCare Pharmaceuticals Inc.
$190
Astellas Pharma US Inc
$182
Eisai Inc.
$155
Daiichi Sankyo Inc.
$155
BeiGene USA, Inc.
$143
Bayer Healthcare Pharmaceuticals Inc.
$118
Regeneron Healthcare Solutions, Inc.
$117
Takeda Pharmaceuticals U.S.A., Inc.
$114
Kite Pharma, Inc.
$110
Boehringer Ingelheim Pharmaceuticals, Inc.
$104
Exelixis Inc.
$100
TAIHO ONCOLOGY, INC.
$92
EMD Serono, Inc.
$90
Pharmacosmos Therapeutics Inc.
$83
TerSera Therapeutics LLC
$80
Stemline Therapeutics Inc.
$77
TESARO, Inc.
$77
SOBI, INC
$71
G1 Therapeutics, Inc.
$71
Puma Biotechnology, Inc.
$69
Blueprint Medicines Corporation
$66
Janssen Pharmaceuticals, Inc
$66
ARRAY BIOPHARMA INC
$66
EISAI INC.
$66
JAZZ PHARMACEUTICALS INC.
$66
Foundation Medicine, Inc.
$64
PharmaEssentia USA Corporation
$57
Lexicon Pharmaceuticals, Inc.
$53
GlaxoSmithKline, LLC.
$51
Mirati Therapeutics, Inc.
$43
CSL Behring
$39
MEDIVATION FIELD SOLUTIONS LLC
$39
MorphoSys, US Inc.
$38
SANOFI-AVENTIS U.S. LLC
$38
Array BioPharma Inc.
$34
AbbVie, Inc.
$34
Smith & Nephew, Inc.
$33
Myriad Genetic Laboratories, Inc.
$33
Genmab U.S., Inc.
$30
CTI BioPharma Corp.
$30
RECORDATI_RARE_DISEASES_INC.
$29
Alexion Pharmaceuticals, Inc.
$28
Heron Therapeutics, Inc.
$28
Alnylam Pharmaceuticals Inc.
$27
Horizon Therapeutics plc
$26
Clovis Oncology, Inc.
$26
Rigel Pharmaceuticals, Inc.
$25
Taiho Oncology, Inc.
$25
Teva Pharmaceuticals USA, Inc.
$25
AMAG Pharmaceuticals, Inc.
$25
NanoString Technologies, Inc.
$24
Adaptive Biotechnologies Corporation
$22
Emmaus Medical, Inc.
$18
Global Blood Therapeutics, Inc.
$18
Sobi, Inc
$17
Coherus Biosciences Inc.
$16
PUMA BIOTECHNOLOGY, INC.
$16
Pharmacyclics LLC, An AbbVie Company
$16
Agios Pharmaceuticals, Inc.
$15
Kyowa Kirin, Inc.
$13
Aurobindo Pharma USA, Inc.
$13
Dova Pharmaceuticals
$13
Secura Bio, Inc.
$9
Veracyte, Inc.
$3
Top 3 companies account for 22.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · AYVAKIT · Abraxane · Afstyla · Alecensa · Avastin · BENDEKA · BESREMI · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ENHERTU · ENJAYMO · ERLEADA · Endari · Enhertu · Epkinly · Erleada · FARYDAK · FERAHEME · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idelvion · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PICO · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · Padcev · Perjeta · Polivy · Pomalyst · Poteligeo · REBLOZYL · RYBREVANT · RYDAPT · Revlimid · Rituxan Hycela · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SUSTOL · SUTENT · SYLVANT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Vanflyta · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XOSPATA · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
9
County median income
$66,581
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH DAYTONA BEACH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khan is a mixed practice specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khan experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Khan performed 17,138 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Khan receive payments from pharmaceutical companies?
Yes. Dr. Khan received a total of $11,435 from 82 companies across 667 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khan's costs compare to other hematologists in Daytona Beach?
Dr. Khan's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Daytona Beach
Browse hematologists in Daytona Beach ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology